Daily Halftime Report: NVDA Continuation Buy-In

Daily Halftime Update: NVDA gapped up on this morning's session to retest it's ATHs at $152.89 which was tested back in Nov 21, 2024. Looking for a entry between $149.5-$149.95 (Target: $149.73) and a close above $148.98 for confirmation of Continuation to retest those ATHs in the weeks to come. Looking for a $160 Price Target on the Long Trade here.